SCHEMBL209740

SCHEMBL209740

CCC(C)N1C(=O)C=CC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 12/20 0.44
ALDH1A1 P00352 3/20 0.44
BLM P54132 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
GMNN O75496 1/20 0.44
THPO P40225 1/20 0.44
PMP22 Q01453 1/20 0.44
GSK3A P49840 2/20 0.38
GSK3B P49841 2/20 0.38
FAAH O00519 4/20 0.35
PTGS1 P23219 3/20 0.35
PTGS2 P35354 3/20 0.35
HPGD P15428 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
WRN Q14191 1/20 0.33
HIF1A Q16665 1/20 0.33
PKM P14618 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24176335 0.85 MGLL (0.37) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL20806156 0.82 MGLL (0.38) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL1535503 0.81 GAA (0.42) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL9117006 0.81 MGLL (0.37) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL1535512 0.79 MGLL (0.35) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL3470187 0.78 MGLL (0.37) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL8095583 0.78 MGLL (0.37) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL3482194 0.78 MGLL (0.37) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL19603733 0.78 MGLL (0.37) MGLLALDH1A1BLMLMNAMAPT
SCHEMBL1535492 0.78 MGLL (0.44) MGLLALDH1A1BLMLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9268076-B2 Optical compensation layer, optical compensation film, and processes for producing these TOSOH CORPORATION (JP) 2016-02-23 US claimed
CN-1125448-A 14-substituted marcfortines and derivatives useful as antiparasitic agents UPJOHN CO (US) 1996-06-26 CN claimed
US-20260099051-A1 INJECTION MOLDED LIGHT-GUIDING MEMBER AND HEAD-MOUNTED DISPLAY ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-04-09 US disclosed
US-20260036719-A1 REFLECTIVE POLARIZER BONDED LENS, HEAD-MOUNTED DISPLAY, AND METHOD FOR PRODUCING REFLECTIVE POLARIZER BONDED LENS ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-02-05 US disclosed
US-20250382405-A1 METHOD FOR PRODUCING N-ALKYLMALEIMIDE COPOLYMER AND N-ALKYLMALEIMIDE COPOLYMER TOSOH CORPORATION (JP) 2025-12-18 US disclosed
CN-120077771-A Curable composition for organic EL element, cured product for organic EL element, method for producing cured product for organic EL element, and polymer JSR株式会社 2025-05-30 CN disclosed
EP-4549476-A1 METHOD FOR PRODUCING N-ALKYLMALEIMIDE COPOLYMER AND N-ALKYLMALEIMIDE COPOLYMER Tosoh Corporation (JP) 2025-05-07 EP disclosed
US-20250059310-A1 METHOD FOR PRODUCING POLYMER, AND RESIN COMPOSITION TOSOH CORPORATION (JP) 2025-02-20 US disclosed
CN-119463010-A Pellets, molded article, and method for producing molded article 旭化成株式会社 2025-02-18 CN disclosed
CN-119427637-A Method for producing plate-shaped molded article 旭化成株式会社 2025-02-14 CN disclosed
CN-119403848-A Method for producing N-alkyl maleimide copolymer, and N-alkyl maleimide copolymer 东曹株式会社 2025-02-07 CN disclosed
EP-0356249-A2 Process for producing rubber-modified thermoplastic resin and a thermoplastic resin composition comprising the modified thermoplastic resin JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1990-02-28 EP disclosed
EP-0334497-A2 Method for production of maleimides NIPPON SHOKUBAI CO., LTD. (JP) 1989-09-27 EP disclosed
US-4851547-A MALEIC ANHYDRIDE, AMINE TO MALEINAMIC ACID; CATALYST OF STRONG ACID AND/OR ITS AMINE SALT NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) 1989-07-25 US disclosed
US-4786738-A RING-CLOSURE IMIDATION OF MALEINAMIC ACIDS NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) 1988-11-22 US disclosed
US-4780546-A ACID CATALYZED CYCLIZATION OF MALEINAMIC ACIDS NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD. (JP) 1988-10-25 US disclosed
EP-0257831-A1 Method for production of maleimides NIPPON SHOKUBAI CO., LTD. (JP) 1988-03-02 EP disclosed
US-4623734-A RING CLOSURE IMIDATION OF MALEAMIC ACID IN APROTIC SOLVENT NIPPON SHOKUBAI KAGAKU KOGYO CO., LTD. (JP) 1986-11-18 US disclosed
EP-0165574-A2 Method for production of maleimides Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) 1985-12-27 EP disclosed
US-4246077-A SILVER COMPLEX OF 3-PYRROLINE-2,5-DIONE OR PYRROLIDINE-2,5-DIONE TECHNIC, INC. (US) 1981-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260099051-A1 INJECTION MOLDED LIGHT-GUIDING MEMBER AND HEAD-MOUNTED DISPLAY NR2E3, STRA6, UACA MGLL 454/4885ALDH1A1 2561/4885BLM 804/4885
US-20260036719-A1 REFLECTIVE POLARIZER BONDED LENS, HEAD-MOUNTED DISPLAY, AND METHOD FOR PRODUCING REFLECTIVE POLARIZER BONDED LENS VCL, CDH1, DSP MGLL 2681/4885ALDH1A1 1628/4885BLM 1570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.